First National Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
First National Advisers's LLY Position: Q3 2026 in Review
First National Advisers reduced its Eli Lilly (LLY) stake by 3.5% in Q3 2026, selling an estimated $378K and leaving 8,897 shares worth $10.3M. The position accounts for 1.4% of the portfolio, ranked #15.
First National Advisers first reported a position in LLY in Q2 2022 and has held it in 18 quarters since. The position peaked at $11.1M in Q4 2025. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- First National Advisers held 8,897 shares of Eli Lilly worth $10.3M as of Q3 2026.
- First National Advisers sold 320 Eli Lilly shares in Q3 2026, an estimated $378K.
- Eli Lilly made up 1.4% of First National Advisers's portfolio in Q3 2026, its #15 holding.
- First National Advisers first reported a position in Eli Lilly in Q2 2022 and has held it in 18 quarters since.
- First National Advisers's Eli Lilly position peaked at $11.1M in Q4 2025.
- 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on First National Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.